GIS
  • About Us
    • Welcome Message
    • GIS Story
    • GIS Brochures
  • News/Events
    • Press Releases
    • News
    • Genome: The GIS Speaker Series
    • Singapore RNA Seminar Series
    • Conferences and Other Seminars
      • #GIS25 Genome Innovation & Precision Medicine Conference
    • RNA Salon Singapore
    • Videos
    • Awards
  • Our People
    • FACULTY Staff
    • Associate Faculty
    • Adjunct Faculty
    • GIS FELLOWS / GIS INNOVATION FELLOW
    • Platform Leaders
    • Programme Managers
    • Research Administration
    • Senior Scientist
    • Scientist
  • Our Science
    • Sequencing Platforms
      • Next Generation Sequencing
      • Genotyping
    • Genome Informatics and AI
      • Artificial Intelligence (AI) at GIS
      • GRIDS
      • Computational Tools and Resources
    • Precision Medicine And Population Genomics
      • Centre for Genome Diagnostics
      • EMULSION
      • NPM
      • Eye Genetics
      • CaLiBRe
      • Operation Stronghold
    • Epigenetic And Epitranscriptomic Regulation
    • Spatial And Single Cell Systems
      • Spatial and Single Cell Genomics Platform
      • Singapore Single-Cell Network
      • Single-Cell In Situ Spatial Omics at Subceullar Resolution
    • Genome Architecture And Design
      • GERMS
      • Asian Skin Microbiome Programme
      • CRISPR Platform
      • Precision Infectious Disease Solutions
    • Disease Research At GIS
      • Oncology Disease Research
      • Eye Disease Research
      • Neurological Disease Research
      • Infectious Disease Research
      • Cardiovascular Disease Research
    • GIS Software for Commercial Licensing
      • MutSpot
      • NDRquant
      • PUREE
      • SMuRFv2
      • VarNet
      • gRNA Designers
      • m6anet
      • proActiv
      • xPore
      • BANKSY
      • DUBStepR
      • RCAv2
  • Join Us
    • Careers
    • Students
    • Partner With Us
  • Contact Us
  • Home
  • A*STAR GIS
  • News/Events
  • Press Releases
  • Press Releases 2022
  • A*STAR GIS
  • About Us
    • Welcome Message
    • GIS Story
    • GIS Brochures
  • News/Events
    • Press Releases
    • News
    • Genome: The GIS Speaker Series
    • Singapore RNA Seminar Series
    • Conferences and Other Seminars
      • #GIS25 Genome Innovation & Precision Medicine Conference
    • RNA Salon Singapore
    • Videos
    • Awards
  • Our People
    • FACULTY Staff
    • Associate Faculty
    • Adjunct Faculty
    • GIS FELLOWS / GIS INNOVATION FELLOW
    • Platform Leaders
    • Programme Managers
    • Research Administration
    • Senior Scientist
    • Scientist
  • Our Science
    • Sequencing Platforms
      • Next Generation Sequencing
      • Genotyping
    • Genome Informatics and AI
      • Artificial Intelligence (AI) at GIS
      • GRIDS
      • Computational Tools and Resources
    • Precision Medicine And Population Genomics
      • Centre for Genome Diagnostics
      • EMULSION
      • NPM
      • Eye Genetics
      • CaLiBRe
      • Operation Stronghold
    • Epigenetic And Epitranscriptomic Regulation
    • Spatial And Single Cell Systems
      • Spatial and Single Cell Genomics Platform
      • Singapore Single-Cell Network
      • Single-Cell In Situ Spatial Omics at Subceullar Resolution
    • Genome Architecture And Design
      • GERMS
      • Asian Skin Microbiome Programme
      • CRISPR Platform
      • Precision Infectious Disease Solutions
    • Disease Research At GIS
      • Oncology Disease Research
      • Eye Disease Research
      • Neurological Disease Research
      • Infectious Disease Research
      • Cardiovascular Disease Research
    • GIS Software for Commercial Licensing
      • MutSpot
      • NDRquant
      • PUREE
      • SMuRFv2
      • VarNet
      • gRNA Designers
      • m6anet
      • proActiv
      • xPore
      • BANKSY
      • DUBStepR
      • RCAv2
  • Join Us
    • Careers
    • Students
    • Partner With Us
  • Contact Us
Agency for Science, Technology and Research (A*STAR)
PartnershipsCareersSuppliersContact UsWhistleblowing
  • Report Vulnerability
  • Privacy Statement
  • Terms & Conditions
    • Press Releases 2022

    GIS' Startup Nalagenetics Raises US$12.6M funds

    25 Mar 2022
    • Whatsapp
    • Telegram
    • Facebook
    • Twitter
    • Email
    • Linked In
    GIS’ Biotech Startup Nalagenetics Raises US$12.6m In Series A Funding Round

    Nalagenetics Team Singapore . Prof Liu Jian Jun, Co-Founder and Super Advisor (1st row, 1st from the left), Levana Sani, Co-Founder and CEO (1st row, 2nd from the left), Astrid Irwanto, Co-Founder and COO (1st row, 4th from the left), and Alexander Lezhava , Co-Founder and Super Advisor (2nd row, 1st from the right).

    Nalagenetics, a spin off from A*STAR’s GIS, was recently featured in the Business Times on 25 March 2022 for raising US$12.6 million in a Series A funding round.

    Founded in 2016, Nalagenetics is a biotechnology company focused on personalised screening and intervention. It aims to provide affordable and actionable end to end genetic testing that is relevant to local populations. The company has four product pillars: Clinical Decision Support for physicians, genetic tests, Knowledge Base and algorithms to generate clinically actionable reports, and Patient Engagement.

    For more information, please visit http://www.nalagenetics.com.